Accessibility Menu
Intuitive Surgical logo

Intuitive Surgical(NASDAQ) ISRG

Market Cap$138.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)+19,391%
5 Year+11%
1 Year-19%
1 Month+13%
$400.35
+2.34%
+9.17Today
Intuitive Surgical last closing stock price
MetricPriceDate
Last closeUSD 391.182026-08-18
Intuitive Surgical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.5%USD 401.232026-08-11
1 month+13.25%USD 345.422026-07-17
3 month-12.88%USD 449.032026-05-20
Year to date-30.93%USD 566.362025-12-31
1 year-18.72%USD 481.282025-08-18
3 year+36.8%USD 285.952023-08-18
5 year+11.17%USD 351.882021-08-19
Since inception+19,391.33%USD 2.012000-06-13

Intuitive Surgical Financials at a Glance

Market Cap

$138.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$11.03B

Net Income (TTM)

$3.14B

EPS (TTM)

$8.73

P/E Ratio

44.83

Dividend

$0.00

Beta (Volatility)

1.27 (Average)

Price

$400.35

Volume

668,641.922

Open

$394.55

Previous Close

$391.18

Daily Range

$394.00 - $405.34

52-Week Range

$328.57 - $603.88

Estimated Earnings Date

Oct 20, 2026

About Intuitive Surgical

Intuitive Surgical, Inc. makes robots that help doctors perform surgery. These systems allow for operations through very small incisions. Patients recover faster and feel less pain after these procedures.

Surgical Tools and Digital Technology

  • Multi-Port Systems: Flagship robotic platforms that allow surgeons to use several small entry points for complex operations.
  • Single-Port Systems: Specialized platform designed for surgeries requiring entry through only one small incision.
  • Endoluminal Systems: Robotic-assisted catheters used for minimally invasive lung biopsies to help diagnose cancer.
  • Instruments and Accessories: Replaceable tools such as staplers and energy devices used during robotic procedures.
  • Support Services: Technical maintenance, clinical training, and repair services for hospitals using robotic systems.

Scaling Global Operations

  • Launched the fifth-generation da Vinci 5 surgical system in 2024 with integrated force feedback technology.
  • Acquired distribution businesses in Italy, Spain, and Portugal to transition toward a direct sales model.
  • Obtained European certification for the da Vinci 5 system in July 2025 for adult and pediatric use.
  • Introduced the Ion system to the Chinese market in the third quarter of 2024 following regulatory approval.

What Makes Intuitive Stand Out?

The company generates 85% of its total revenue from recurring sources like instrument replacements and service contracts. It supports a global network of 11,710 installed robotic systems as of June 30, 2026.

Strength in the Numbers

  • Total revenue rose 19% year over year to $2.89 billion during the three-month period ended June 30, 2026.
  • Operating income reached $972 million in the second quarter of 2026, up 31% compared to the prior year.
  • The company held $8.63 billion in cash, cash equivalents, and investments as of June 30, 2026.
  • Da Vinci procedure volume grew 15% year over year during the three-month period ended June 30, 2026.
  • The P/E ratio was 42.9 in the second quarter of 2026, compared to 73.8 during the same period in 2025.

Bottom Line

Intuitive has evolved from a robotic pioneer into a provider of connected digital surgical ecosystems. Its focus on minimally invasive care supports a massive installed base and consistent recurring revenue.

AI Generated • Jul 22, 2026

Industry

Healthcare Equipment and Supplies

Employees

17,021

CEO

Dave Rosa Rosa

Headquarters

Sunnyvale, CA 94086-5304, US

ISRG Financials

Key Financial Metrics (TTM)

Gross Margin

66.68%

Operating Margin

31.28%

Net Income Margin

28.45%

Return on Equity

17.83%

Return on Capital

16.25%

Return on Assets

15.04%

Earnings Yield

2.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$138.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

353.28M

Volume

668.64K

Avg. Volume

3.11M

Financials (TTM)

Gross Profit

$7.36B

Operating Income

$3.45B

EBITDA

$4.51B

Operating Cash Flow

$3.71B

Capital Expenditure

-$483.80M

Free Cash Flow

$3.22B

Cash & ST Invst.

$5.22B

Total Debt

$0.00

Intuitive Surgical Performance Analysis

Intuitive Surgical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 6,222,200,0009.0%
20232023-12-31USD 7,124,100,00014.5%
20242024-12-31USD 8,352,100,00017.2%
20252025-12-31USD 10,064,700,00020.5%
Intuitive Surgical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-302.7%
Q42025-12-3114.4%
Q12026-03-31-3.3%
Q22026-06-304.4%
Intuitive Surgical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 3.65-21.6%
20232023-12-31USD 5.0337.7%
20242024-12-31USD 6.4227.5%
20252025-12-31USD 7.8722.7%
Intuitive Surgical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.7%
Q42025-12-3113.3%
Q12026-03-313.2%
Q22026-06-303.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.89B

+18.5%

Gross Profit

$1.96B

+21.2%

Gross Margin

67.78%

N/A

Market Cap

$138.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$8.12M

N/A

Employees

17,021

N/A

Net Income

$818.10M

+24.3%

EBITDA

$1.17B

+18.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$5.22B

-2.1%

Total Debt

$0.00

N/A

Accounts Receivable

$1.77B

+27.3%

Inventory

$2.03B

+21.7%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

15.04%

N/A

Return on Invested Capital

18.21%

N/A

Free Cash Flow

$948.40M

+69.3%

Operating Cash Flow

$1.06B

+48.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BDXBecton, Dickinson and Company
$186.31+3.06%
RMDResMed Inc.
$227.62+3.47%
WSTWest Pharmaceutical Services, Inc.
$354.79+2.37%
HOLXHologic, Inc.
$76.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MRNAModerna
$140.50+1.23%
IBITiShares Bitcoin Trust
$38.79+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$9.26+0.06%
INTCIntel
$93.22-0.04%

Questions About ISRG

What is the current price of Intuitive Surgical?

Intuitive Surgical is trading at $400.04 per share.

What is the 52-week range for Intuitive Surgical?

Over the past 52 weeks, Intuitive Surgical has traded between $328.57 and $603.88.

How much debt does Intuitive Surgical have?

As of the most recent reporting period, Intuitive Surgical reported total debt of $0.00.

How much cash does Intuitive Surgical have on hand?

Intuitive Surgical reported $2.79B in cash and cash equivalents in its most recent financial results.

What is Intuitive Surgical’s dividend yield?

Intuitive Surgical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.